Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Hengrui Medical Devices is a specialized subsidiary of Jiangsu Hengrui Pharmaceuticals, focusing on the research, development, and manufacturing of high-end medical devices. The company primarily operates in the fields of interventional cardiology, peripheral vascular intervention, and interventional oncology. Its product portfolio includes drug-eluting stents, balloon catheters, and various interventional accessories. Suzhou Hengrui leverages the extensive R&D capabilities of its parent company to provide innovative solutions for minimally invasive procedures. The company is headquartered in the Suzhou Industrial Park, a major hub for biotech and medical technology in China. It maintains state-of-the-art manufacturing facilities that comply with international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Hengrui Medical Devices.